Michael Gelband’s Embecta EMBC Stock Holding History

Michael Gelband’s Portfolio EMBC Stock Details EMBC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-39,252	Closed	-$591K	–	1616
2023 Q3	$591K	Sell	39,252 -41,556	-51%	-$779K	0.01%	1176
2023 Q2	$1.75M	Buy	80,808 +40,677	+101%	+$1.11M	0.01%	864
2023 Q1	$1.13M	Buy	+40,131	New	+$1.14M	0.01%	1100
2022 Q4	–	Sell	-24,149	Closed	-$695K	–	1753
2022 Q3	$695K	Buy	+24,149	New	+$715K	0.01%	1252

Other funds holding EMBC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

RRAM

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

YAM

Yacktman Asset Management Austin, Texas $8.09B AUM 19.03% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Michael Gelband's EMBC Position: Q4 2023 in Review

Michael Gelband sold out of Embecta (EMBC) in Q4 2023, closing a stake of 39,252 shares — an estimated $591K sold.

Michael Gelband first reported a position in EMBC in Q3 2022 and held it in 4 quarters. The position peaked at $1.75M in Q2 2023. 374 funds tracked by Wall St. Rank hold EMBC as of Q4 2023.

Michael Gelband reported no remaining Embecta position as of Q4 2023 after selling out during the quarter.
Michael Gelband sold 39,252 Embecta shares in Q4 2023, an estimated $591K.
Michael Gelband first reported a position in Embecta in Q3 2022 and held it in 4 quarters.
Michael Gelband's Embecta position peaked at $1.75M in Q2 2023.
374 funds tracked by Wall St. Rank held Embecta as of Q4 2023.

Based on ExodusPoint Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.